High Falls Advisors’s iShares Biotechnology ETF IBB Stock Holding History

High Falls Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,304	Closed	-$857K	–	132
2021 Q3	$857K	Buy	+5,304	New	+$893K	0.23%	45
2020 Q3	–	Sell	-7,339	Closed	-$1M	–	53
2020 Q2	$1M	Sell	7,339 -468	-6%	-$59.7K	0.37%	38
2020 Q1	$841K	Buy	7,807 +3	+0%	+$345	0.34%	31
2019 Q4	$940K	Buy	+7,804	New	+$871K	0.26%	41
2017 Q2	–	Sell	-5,361	Closed	-$524K	–	88
2017 Q1	$524K	Buy	+5,361	New	+$513K	0.23%	46
2016 Q3	–	Sell	-900	Closed	-$101K	–	94
2016 Q2	$101K	Hold	900	–	–	0.03%	96
2016 Q1	$78K	Hold	900	–	–	0.03%	105
2015 Q4	$101K	Buy	+900	New	+$97.7K	0.03%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

High Falls Advisors's IBB Position: Q4 2021 in Review

High Falls Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 5,304 shares — an estimated $857K sold.

High Falls Advisors first reported a position in IBB in Q4 2015 and held it in 8 quarters. The position peaked at $1M in Q2 2020. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

High Falls Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
High Falls Advisors sold 5,304 iShares Biotechnology ETF shares in Q4 2021, an estimated $857K.
High Falls Advisors first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 8 quarters.
High Falls Advisors's iShares Biotechnology ETF position peaked at $1M in Q2 2020.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on High Falls Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.